Latest news

December 2, 2025

A New Milestone Brings Hope to People Living With FCS

Recently, US health regulators (the Food and Drug Administration, FDA) green‑lit a new treatment for adults with familial chylomicronaemia syndrome (FCS), a rare and often devastating genetic disease. For people who face this condition every day, the decision represents more than just a new drug on the market. It offers real hope for a life […]
Read more
November 28, 2025

FHEF November 2025 Edition Heart Beat Newsletter

November brought strong progress for FH Europe Foundation, with impactful advocacy, a successful Annual Network Meeting and growing recognition for prevention-focused projects. FH Europe Foundation News: Annual Network Meeting (Zagreb): Over 100 participants came together under the theme “Together, engaged for change!”, strengthening collaboration across the network. European Parliament Event: FHEF joined policymakers and experts […]
Read more
November 28, 2025

FH Europe CEO Joins WHO Expert Group on Dyslipidaemia

Magdalena Daccord, CEO of the FH Europe Foundation, has been selected by the World Health Organisation (WHO) as an expert member of the Guideline Development Group (GDG) on dyslipidaemia. She will contribute strictly in her individual and independent capacity, in full accordance with WHO rules, and not on behalf of any organisation. The WHO, the […]
Read more
November 27, 2025

Prevention in a Fragmenting World: Key Insights from the World Health Summit for Cardiovascular & Inherited Lipid Disorders

The World Health Summit 2025 delivered a clear message: global health systems are under pressure because we treat disease too late, not because prevention is impossible. For cardiovascular disease (CVD) and inherited lipid disorders, the summit’s conclusions strongly reinforce the need for earlier detection, stronger primary care, and policies that support long-term prevention. Prevention as […]
Read more
Join our mailing list to receive our monthly newsletter - Heart Beat
Mailchimp Enews Signup